# Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/par-22-250-centers-of-biomedical-research-excellence-cobre-phase-1/  
Official notice: https://www.grants.gov/search-results-detail/343483

> National Institutes of Health offered grants of up to $1.5 million to state and local governments. Applications closed on January 30, 2025.

| Field | Value |
|---|---|
| Opportunity number | PAR-22-250 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | January 30, 2025 |
| Award ceiling | $1.5 million |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.859 |

## Who can apply

- State governments

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Nonprofits Other Than Institutions of Higher Education Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

## What the grant funds

The National Institute of General Medical Sciences (NIGMS) invites applications for renewal of eligible Centers of Biomedical Research Excellence (COBRE) grants. The objective of the COBRE initiative is to strengthen an institution's biomedical research infrastructure through the establishment of a thematic, multi-disciplinary center and to enhance the ability of investigators to compete independently for NIH individual research grants or other external peer-reviewed support. COBRE awards are supported through the Institutional Development Award (IDeA) Program, which aims to foster health-related research by increasing the competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from the NIH. The goal of this FOA is to support existing COBRE Phase 1 Centers by further strengthening the research infrastructure and to continue the development and support of a critical mass of investigators with the expertise in the Center's scientific interest areas.

## Questions people ask

### Is PAR-22-250 still open?

No. It closed on January 30, 2025.

### Who can apply for Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)?

National Institutes of Health accepted applications from state and local governments. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)?

Closed January 30, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $1.5 million each.

### Who has been funded under PAR-22-250?

NIH RePORTER lists 27 projects funded under PAR-22-250 in fiscal 2024 to 2026, at 26 institutions. The most were at Univ of Arkansas for Med Scis, University of New England, Dartmouth-Hitchcock Clinic.

### Who has won Biomedical Research and Research Training grants before?

The largest recipients over five fiscal years were The Leland Stanford Junior University, Regents of the University of Michigan, University of California, San Diego. The program made 11,631 awards worth $15 billion in that time.